Search - tctmd.com

Displaying 821 - 840 of 1483

Sort: Relevancy | Date

Presentation TCT 2018

What is the Future of Bioresorbable Scaffolds?

Presenter: Jeroen J. Bax, Stephan Windecker, Michael Haude

September 21, 2018

Presentation TCT 2018

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Presenter: Jeroen J. Bax, Stephan Windecker, Robert A. Byrne

September 21, 2018

Presentation TCT 2018

Coronary Artery Disease: Pathology and Pathogenesis

Presenter: David A. Cox, Henning Kelbæk, Grzegorz L. Kaluza

September 21, 2018

Presentation TCT 2018

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Presenter: Jeroen J. Bax, Stephan Windecker, Javier Escaned

September 21, 2018

Presentation TCT 2018

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

Presenter: Jeroen J. Bax, Stephan Windecker, Adrian P. Banning

September 21, 2018

Presentation TCT 2018

CT Angiography Versus Ischemia Testing for Detection of Coronary Artery Disease

Presenter: Jeroen J. Bax, Stephan Windecker

September 21, 2018

News Conference News TCT 2018

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

Shelley Wood

September 17, 2018

News Daily News

FDA Approves New Covered Stent Option for Coronary Perforations

Todd Neale

September 14, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

Presentation ESC 2018

Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2

Presenter: Raban V. Jeger

August 31, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Todd Neale

August 28, 2018

News Conference News ESC 2018

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

Shelley Wood

August 28, 2018

News Conference News ESC 2018

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

Michael O'Riordan

August 27, 2018

News Conference News ESC 2018

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

Shelley Wood

August 25, 2018

News Conference News ESC 2018

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

Todd Neale

August 25, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

Podcast TCTMD Talking Points

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

August 22, 2018

News Daily News

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

Michael O'Riordan

August 16, 2018

Podcast TCTMD Talking Points

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

August 15, 2018

Advertisement

What is the Future of Bioresorbable Scaffolds?

The New 2018 ESC/EACTS Guidelines on Myocardial Revascularization: Focus on Multivessel and Left Main Disease

Coronary Artery Disease: Pathology and Pathogenesis

Novel Hemodynamic Assessment Parameters and Intracoronary Imaging to Optimize PCI Outcomes

Beyond ORBITA: The Role of PCI in Stable Ischemic CAD

CT Angiography Versus Ischemia Testing for Detection of Coronary Artery Disease

TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More

FDA Approves New Covered Stent Option for Coronary Perforations

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Drug-Coated Balloons for Small Coronary Artery Disease: BASKET-SMALL 2

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

BASKET-SMALL 2: Drug-Coated Balloon Fares Well Against DES for De Novo Small-Vessel Disease

Pretreatment With P2Y12 Inhibitors Questioned Anew in SCAAR

GLOBAL LEADERS: Ticagrelor Monotherapy Fails to Beat Conventional DAPT After PCI

CLARIFY: No Survival Benefit With Beta-Blockers Beyond 1 Year Post-MI in Stable CAD

CULPRIT-SHOCK: 1-Year Results Continue to Support Culprit-Only PCI for Shock Patients

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

ABSORB III: 3-Year Outcomes From a Randomized Trial of a Bioresorbable Scaffold vs a Metallic DES in Patients With Coronary Artery Disease

Genetic Risk Score Identifies Individuals at Heightened Risk of CAD and Other Diseases

REVASC: A Randomized Trial to Assess Recovery of Left Ventricular Function After PCI of Coronary Artery Chronic Total Occlusions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content